Literature DB >> 18724825

Relationship of pneumocystis antibody response to severity of chronic obstructive pulmonary disease.

Alison Morris1, Mahesh Netravali, Heather M Kling, Timothy Shipley, Ted Ross, Frank C Sciurba, Karen A Norris.   

Abstract

Pneumocystis colonization has been associated with severity of chronic obstructive pulmonary disease (COPD). The relationship of Pneumocystis antibody status to COPD severity has not been investigated, but antibody levels might relate to both colonization susceptibility and COPD progression. We investigated anti-Pneumocystis antibody titers and airway obstruction in a cohort of patients with COPD. Undetectable anti-Pneumocystis antibody titer was an independent predictor of more-severe airway obstruction, although use of inhaled corticosteroids is a possible confounder of this effect.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18724825      PMCID： PMC2602869          DOI： 10.1086/591701

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  17 in total

1.  Amplification of inflammation in emphysema and its association with latent adenoviral infection.

Authors:  I Retamales; W M Elliott; B Meshi; H O Coxson; P D Pare; F C Sciurba; R M Rogers; S Hayashi; J C Hogg
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

2.  CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease.

Authors:  M Saetta; A Di Stefano; G Turato; F M Facchini; L Corbino; C E Mapp; P Maestrelli; A Ciaccia; L M Fabbri
Journal:  Am J Respir Crit Care Med       Date:  1998-03       Impact factor: 21.405

3.  Pneumocystis carinii infection in patients with chronic bronchial disease.

Authors:  E J Calderón; C Regordan; F J Medrano; M Ollero; J M Varela
Journal:  Lancet       Date:  1996-04-06       Impact factor: 79.321

Review 4.  Bacterial infection and the pathogenesis of COPD.

Authors:  S Sethi
Journal:  Chest       Date:  2000-05       Impact factor: 9.410

5.  Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization.

Authors:  Alison Morris; Frank C Sciurba; Irina P Lebedeva; Andrew Githaiga; W Mark Elliott; James C Hogg; Laurence Huang; Karen A Norris
Journal:  Am J Respir Crit Care Med       Date:  2004-04-29       Impact factor: 21.405

6.  Reference spirometric values using techniques and equipment that meet ATS recommendations.

Authors:  R O Crapo; A H Morris; R M Gardner
Journal:  Am Rev Respir Dis       Date:  1981-06

7.  Quantitation of anti-Pneumocystis jiroveci antibodies in healthy persons and immunocompromised patients.

Authors:  Lisa R Bishop; Joseph A Kovacs
Journal:  J Infect Dis       Date:  2003-05-29       Impact factor: 5.226

8.  Standardized single breath normal values for carbon monoxide diffusing capacity.

Authors:  R O Crapo; A H Morris
Journal:  Am Rev Respir Dis       Date:  1981-02

9.  Serologic responses to epitopes of the major surface glycoprotein of Pneumocystis jiroveci differ in human immunodeficiency virus-infected and uninfected persons.

Authors:  Kieran R Daly; Carl J Fichtenbaum; Reiko Tanaka; Michael J Linke; Robert O'Bert; Timothy D Thullen; Michele S Hui; Alan G Smulian; Peter D Walzer
Journal:  J Infect Dis       Date:  2002-08-09       Impact factor: 5.226

10.  Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle.

Authors:  Rick A Bright; Donald M Carter; Corey J Crevar; Franklin R Toapanta; Jonathan D Steckbeck; Kelly S Cole; Niranjan M Kumar; Peter Pushko; Gale Smith; Terrence M Tumpey; Ted M Ross
Journal:  PLoS One       Date:  2008-01-30       Impact factor: 3.240
View more
  20 in total

1.  Trimethoprim-sulfamethoxazole treatment does not reverse obstructive pulmonary changes in pneumocystis-colonized nonhuman primates with SHIV infection.

Authors:  Heather M Kling; Timothy W Shipley; Siobhan Guyach; Rebecca Tarantelli; Alison Morris; Karen A Norris
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

2.  Decreased serum antibody responses to recombinant pneumocystis antigens in HIV-infected and uninfected current smokers.

Authors:  Kristina Crothers; Kieran R Daly; David Rimland; Matthew Bidwell Goetz; Cynthia L Gibert; Adeel A Butt; Amy C Justice; Kpandja Djawe; Linda Levin; Peter D Walzer
Journal:  Clin Vaccine Immunol       Date:  2010-12-29

3.  Pneumocystis infection and the pathogenesis of chronic obstructive pulmonary disease.

Authors:  Karen A Norris; Alison Morris
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

4.  Serologic responses to pneumocystis proteins in HIV patients with and without Pneumocystis jirovecii pneumonia.

Authors:  Matthew R Gingo; Lorrie Lucht; Kieran R Daly; Kpandja Djawe; Frank J Palella; Alison G Abraham; Jay H Bream; Mallory D Witt; Lawrence A Kingsley; Karen A Norris; Peter D Walzer; Alison Morris
Journal:  J Acquir Immune Defic Syndr       Date:  2011-07-01       Impact factor: 3.731

5.  A new method for the detection of Pneumocystis jirovecii using flow cytometry.

Authors:  J Barbosa; C Bragada; S Costa-de-Oliveira; E Ricardo; A G Rodrigues; C Pina-Vaz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-16       Impact factor: 3.267

Review 6.  Colonization by Pneumocystis jirovecii and its role in disease.

Authors:  Alison Morris; Karen A Norris
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

7.  Pneumocystis infection alters the activation state of pulmonary macrophages.

Authors:  Jessica M Deckman; Cathryn J Kurkjian; Joseph P McGillis; Theodore J Cory; Susan E Birket; Linda M Schutzman; Brian S Murphy; Beth A Garvy; David J Feola
Journal:  Immunobiology       Date:  2016-10-05       Impact factor: 3.144

8.  Vaccine-Induced Immunogenicity and Protection Against Pneumocystis Pneumonia in a Nonhuman Primate Model of HIV and Pneumocystis Coinfection.

Authors:  Heather M Kling; Karen A Norris
Journal:  J Infect Dis       Date:  2016-01-27       Impact factor: 5.226

9.  Long-term serologic responses to the Pneumocystis jirovecii major surface glycoprotein in HIV-positive individuals with and without P. jirovecii infection.

Authors:  Peter D Walzer; Kpandja Djawe; Linda Levin; Kieran R Daly; Judith Koch; Lawrence Kingsley; Mallory Witt; Elizabeth T Golub; Jay H Bream; Babafemi Taiwo; Alison Morris
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

10.  Modulation of inflammasome-mediated pulmonary immune activation by type I IFNs protects bone marrow homeostasis during systemic responses to Pneumocystis lung infection.

Authors:  Steve Searles; Katherine Gauss; Michelle Wilkison; Teri R Hoyt; Erin Dobrinen; Nicole Meissner
Journal:  J Immunol       Date:  2013-08-23       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.